Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Pinata Holdings Inc. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed between 2 distinct examiners and 2 distinct art units, indicating a split focus for the current filings.
The busiest examiner, MINA HAGHIGHATIAN, is responsible for 1 pending office action. This means that each of the pending office actions is being reviewed by a different examiner in a separate art unit, requiring the company to navigate distinct technical requirements.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HAGHIGHATIAN, MINA | 1 | 46.0% | +39.4% |
| VAN BUREN, LAUREN K | 1 | 40.0% | +58.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18561351 | Inhalable Pharmaceutical Formulations | HAGHIGHATIAN, MINA | — |
| 18558215 | Delivery of Cellular Material and Other Material as a Dry Powder | VAN BUREN, LAUREN K | — |
| Art Unit | Apps |
|---|---|
| 1616 | 1 |
| 1638 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18561351 | Inhalable Pharmaceutical Formulations | HAGHIGHATIAN, MINA | 1616 | §103Other | Final Rejection | — | Pending | Nov 16, 2023 |
| 18558215 | Delivery of Cellular Material and Other Material as a Dry Powder | VAN BUREN, LAUREN K | 1638 | §103 | Final Rejection | — | Pending | Oct 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPinata Holdings Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Mina Haghighatian has the most, with 1 of Pinata Holdings Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
